Dr. PIERRE MAISON-BLANCHE
Cardiologue

Parcours

Praticien associé des Hôpitaux de Paris
Ancien interne des hôpitaux de Paris

Publications

Evaluation of the Effects of CHF6001, an Inhaled PDE4 Inhibitor, on Cardiac Repolarization and Cardiac Arrhythmias in Healthy Volunteers. Ferrari A, Compagnoni A, Nandeuil A, Maison-Blanche P J Cardiovasc Pharmacol. 2016 Jul;68(1):41-8. doi: 10.1097/FJC.0000000000000384.
Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel H3-receptor antagonist/inverse agonist. Shah RR, Maison-Blanche P, Robert P, Denis E, Duvauchelle T. Eur J Clin Pharmacol. 2016 May;72(5):533-43. doi: 10.1007/s00228-016-2023-3. Epub 2016 Feb 16.
Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study. Shah RR, Maison-Blanche P, Duvauchelle T, Robert P, Denis E. Eur J Clin Pharmacol. 2015 Dec;71(12):1451-9. doi: 10.1007/s00228-015-1959-z. Epub 2015 Oct 1.

Calculer l'itinéraire